HAVCR2 and Miyoshi myopathy: HMGB1 was dominantly expressed in RPMI8226, while CEACAM-1 was dominantly expressed in MM.1S, indicating differences in Tim-3 ligand usage in different MM cell lines or cells (Figures 2C–F).